N-Acetylgalactosamine-4-Sulfatase clinical trials
Also written N-acetylgalactosamine 4-sulfatase.
Counted the way a researcher would: N-Acetylgalactosamine-4-Sulfatase with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses N-Acetylgalactosamine-4-Sulfatase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 31 May 2005 · NAGLAZYME · BLA 125117 (FDA, Drugs@FDA)
- European Union
- 23 Jan 2006 · Naglazyme · EMEA/H/C/000640 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Related medicines
As reviewed, each with the page that says it.
- Galsulfase is a recombinant medicine of it, counted here with related medicines source
Studies
Open first, then newest update. How each study uses N-Acetylgalactosamine-4-Sulfatase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Study of rhASB in Patients With Mucopolysaccharidosis VICompletedPhase 3BioMarin PharmaceuticalNCT00104234Written as N-acetylgalactosamine 4-sulfatase
- Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VICompletedPhase 3BioMarin PharmaceuticalNCT00067470Written as N-acetylgalactosamine 4-sulfatase
- Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VICompletedPhase 2BioMarin PharmaceuticalNCT00048711Written as N-acetylgalactosamine 4-sulfatase
- Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VICompletedPhase 1BioMarin PharmaceuticalNCT00048620Written as N-acetylgalactosamine 4-sulfatase
Codes
What other systems call N-Acetylgalactosamine-4-Sulfatase · ClinicalTrials.gg INT008746
- RxNorm 578033One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 578033 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.